The Journal of rheumatology · 1998
Increased plasma granulocyte elastase levels in Behçet's disease.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tsutsui K, Hasegawa M, Takata M, Takehara K
Аннотация
OBJECTIVE: To assess the role of granulocyte elastase in the development of thromboembolic vasculopathy in patients with Behçet's disease.
METHODS: Plasma granulocyte elastase-alpha1-proteinase inhibitor (E-PI) complex levels were measured by ELISA in 11 healthy subjects and 19 patients with Behçet's disease (BD). Eight of 19 patients showed deep vein thrombosis on (99m)technetium-macro-agglutinate albumin venography. Hemostatic variables were measured at the same time.
RESULTS: The mean plasma E-PI complex level was significantly higher in the 8 patients with than in the 11 patients without deep vein thrombosis (242 +/- 73 vs 165 +/- 97 ng/ml; p = 0.033). The mean plasma E-PI complex level in the 11 patients without deep vein thrombosis was significantly higher than in controls (165 +/- 97 vs 96 +/- 40 ng/ml; p = 0.038). Plasma E-PI complex levels correlated with the serum plasmin-alpha2-plasmin inhibitor complex levels (r = 0.621, p = 0.0084).
CONCLUSION: Plasma E-PI complex levels appear to be a useful marker of thromboembolic vasculopathy in BD.
METHODS: Plasma granulocyte elastase-alpha1-proteinase inhibitor (E-PI) complex levels were measured by ELISA in 11 healthy subjects and 19 patients with Behçet's disease (BD). Eight of 19 patients showed deep vein thrombosis on (99m)technetium-macro-agglutinate albumin venography. Hemostatic variables were measured at the same time.
RESULTS: The mean plasma E-PI complex level was significantly higher in the 8 patients with than in the 11 patients without deep vein thrombosis (242 +/- 73 vs 165 +/- 97 ng/ml; p = 0.033). The mean plasma E-PI complex level in the 11 patients without deep vein thrombosis was significantly higher than in controls (165 +/- 97 vs 96 +/- 40 ng/ml; p = 0.038). Plasma E-PI complex levels correlated with the serum plasmin-alpha2-plasmin inhibitor complex levels (r = 0.621, p = 0.0084).
CONCLUSION: Plasma E-PI complex levels appear to be a useful marker of thromboembolic vasculopathy in BD.